BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  Direct Relief Commits Initial $2 Million for U.S. Coronavirus Response

  Direct Relief has committed an initial $2 million in emergency funding to support the fight against novel coronavirus in the U.S. as national health officials warn of its expected spread.

  February 27, 2020

   · 

  3 min read
• Business

  ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders held on February 27, 2020

  ESSA Pharma Inc. is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on February 27, 2020 in Vancouver, British Columbia, Canada.

  February 27, 2020

   · 

  6 min read
• Deals

  Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results

  Definitive merger agreement with Forte Biosciences announced February 19, 2020

  February 27, 2020

   · 

  6 min read
• Business

  Trovagene Announces Fourth Quarter and Full-Year 2019 Results

  Trovagene, Inc. (Nasdaq: TROV), today announced company highlights and financial results for the fourth quarter and full-year ended December 31, 2019.

  February 27, 2020

   · 

  12 min read
• Business

  Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results

  Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the fourth quarter and full-year ended December 31, 2019.

  February 27, 2020

   · 

  10 min read
• Business

  Aimmune Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Recent Operational Highlights

  Aimmune Therapeutics, Inc. (Nasdaq: AIMT), today announced financial results for the fourth quarter and full year 2019.

  February 27, 2020

   · 

  19 min read
• Biotech Beach

  Glaukos Corporation Announces Fourth Quarter and Full Year 2019 Financial Results

  Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results.

  February 27, 2020

   · 

  18 min read
• Biotech Bay

  Varian to Attend Upcoming Investor Events in March 2020

  Varian announced that J. Michael Bruff, chief financial officer and Anshul Maheshwari, vice president, investor relations and treasurer will be participating in the following investor conferences

  February 27, 2020

   · 

  1 min read
• Business

  CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business Update Company to Host a Conference Call Today, February 27, 2020, at 5:00 p.m. ET / 2:00 p.m. PT

  CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, today reported full-year 2019 financial results.

  February 27, 2020

   · 

  13 min read
• Business

  Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

  Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced its fourth quarter and full year 2019 financial results and business highlights.

  February 27, 2020

   · 

  13 min read